|
HSP90AB2P expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.222000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.068800E-01 |
| Normal-vs-Stage2 |
2.762200E-01 |
| Normal-vs-Stage3 |
1.732630E-01 |
| Normal-vs-Stage4 |
3.368000E-02 |
| Stage1-vs-Stage2 |
2.181000E-01 |
| Stage1-vs-Stage3 |
5.696300E-02 |
| Stage1-vs-Stage4 |
2.730500E-02 |
| Stage2-vs-Stage3 |
7.729800E-01 |
| Stage2-vs-Stage4 |
2.503200E-01 |
| Stage3-vs-Stage4 |
5.163500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.373800E-01 |
| Normal-vs-AfricanAmerican |
1.581420E-01 |
| Normal-vs-Asian |
1.287600E-01 |
| Caucasian-vs-AfricanAmerican |
1.932960E-01 |
| Caucasian-vs-Asian |
2.432200E-02 |
| AfricanAmerican-vs-Asian |
6.266200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.514000E-01 |
| Normal-vs-Female |
1.440040E-01 |
| Male-vs-Female |
6.014000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.502000E-01 |
| Normal-vs-Extreme_Weight |
7.131000E-01 |
| Normal-vs-Obese |
1.199600E-01 |
| Normal-vs-Extreme_Obese |
3.258800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.297800E-01 |
| Normal_Weight-vs-Obese |
2.083200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.836800E-01 |
| Extreme_Weight-vs-Obese |
3.822500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.771400E-01 |
| Obese-vs-Extreme_Obese |
4.271800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.602000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.705400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.192200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.039270E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.062300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.380200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.954550E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.355600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.897590E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.51770000003759E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.659200E-01 |
| Normal-VS-Type2 PRCC |
1.009210E-01 |
| Normal-VS-KIRP CIMP |
6.204300E-03 |
| Normal-VS-Unclassified PRCC |
5.447600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.258200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.253760E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.926800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.890500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.361500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.281600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.917600E-01 |
| Normal-vs-N1 |
6.831800E-02 |
| Normal-vs-N2 |
8.194400E-01 |
| N0-vs-N1 |
6.548200E-02 |
| N0-vs-N2 |
8.090800E-01 |
| N1-vs-N2 |
9.084200E-02 |
|
|
